• Dry Cracked Skin
  • Impetigo
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Surgery
  • Melasma
  • NP and PA
  • Anti-Aging
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Inflamed Skin

Derm In The News: December 31-January 6


Keep up with the latest headlines in dermatology from the past week, including a successful year for the Skin of Color Society, a rise in skin clinic visits attributed to carbon monoxide levels, and more.

HAPPI: The Skin of Color Society Reports Banner Year of Progress Toward Diversity, Inclusion in Dermatology

In 2023, the Skin of Color Society (SOCS) reported strides in diversifying dermatology through initiatives such as the "Meeting the Challenge Summit" and "My Best Winter Skin Day" campaign. Collaborating with the Dermatology Foundation, SOCS introduced the Sanofi-Regeneron Diversity, Equity, and Inclusion Mid-Career Award, providing a one-million-dollar grant for research addressing healthcare disparities. The organization also conducted its first Scientific Session at the World Congress of Dermatology, released an educational video series, and held the 19th Annual SOCS Scientific Symposium.

Physician's Weekly: Skin Clinic Visits Increased With High Carbon Monoxide Levels Due to Wildfires

A study published in Dermatology and Therapy revealed a correlation between increased carbon monoxide (CO) levels during the Canadian wildfires of 2023 and a rise in atopic dermatitis (AD), dermatitis, and eczema-related clinic visits in a Boston hospital system. Researchers from Massachusetts General Hospital analyzed CO levels in the Boston region following the wildfires and examined patient records from the Mass General Brigham hospital system. The study observed a notable increase and atypical summer peak in CO levels in 2023, correlating with a spike in dermatological clinic visits compared to the previous four years.

Daily Mail: Doctors report 'nightmare' surge in scabies amid shortage of medicines to treat the highly contagious itchy skin condition that's caused by tiny mites

A significant surge in scabies cases in the UK, attributed to a doubling of infection rates in a year, is causing public health concerns. The outbreak is linked to the Canadian wildfires of 2023, with carbon monoxide levels correlated to an increase in scabies-related clinic visits. Medication shortages and fears of the parasite developing resistance to existing drugs compound the issue. Experts emphasize the need for coordinated efforts to improve air quality and ensure an adequate supply of effective treatments. The surge in scabies cases is putting additional strain on health care systems already dealing with medication shortages and challenges in social care.

News Medical: Missing proteins explain century-old mystery of scalp skin absence in children

Children born with aplasia cutis congenita often exhibit additional health issues, such as kidney or heart problems, depending on mutations in the KCTD1 or KCTD15 genes. Researchers from Massachusetts General Hospital investigated these mutations by modeling them in cells and mice. They discovered that the defects lead to the impairment of cells in the midline cranial sutures, which normally express growth factors for skin formation over the skull. The study, published in The Journal of Clinical Investigation, revealed that ACC-related mutations result in a lack of function of the KCTD1 and KCTD15 proteins.

Have you seen any dermatology headlines this week that we may have missed? Share with us by emailing our team at DTEditor@mmhgroup.com.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.